• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?

作者信息

Melamed E, Achiron A, Shapira A, Davidovicz S

机构信息

Department of Neurology, Beilinson Medical Center, Petah Tiqva, Israel.

出版信息

Clin Neuropharmacol. 1991 Jun;14(3):273-8. doi: 10.1097/00002826-199106000-00013.

DOI:10.1097/00002826-199106000-00013
PMID:1676933
Abstract

Drug-induced parkinsonism is usually reversible, except in a small percentage of elderly patients. We describe two relatively young patients, who developed drug-induced parkinsonism during chronic treatment with neuroleptics for a psychotic disorder. Parkinsonism persisted, and markedly and progressively deteriorated after discontinuation of neuroleptic drugs. One patient had tremor as the most prominent sign and the other had mainly an akinetic-rigid syndrome. Neither had ever developed tardive dyskinesia. Both responded to levodopa therapy. Persistent drug-induced parkinsonism in our, and other reported on, elderly patients may be due to unmasking of preexisting subclinical idiopathic Parkinson's disease by neuroleptics. Theoretically, these drugs may precipitate degeneration of vulnerable, nigrostriatal neurons by generating cytotoxic free radicals or by attrition, due to accelerated neuronal firing rates.

摘要

相似文献

1
Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?
Clin Neuropharmacol. 1991 Jun;14(3):273-8. doi: 10.1097/00002826-199106000-00013.
2
Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.迟发性运动障碍患者药物性帕金森综合征的危险因素。
J Clin Psychiatry. 1988 Apr;49(4):139-41.
3
Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.严重帕金森症与迟发性运动障碍并存作为抗精神病药物治疗的副作用。
J Clin Psychiatry. 1984 Jan;45(1):28-30.
4
The coexistence of parkinsonism-like symptoms and tardive dyskinesia.帕金森综合征样症状与迟发性运动障碍并存。
Am J Psychiatry. 1982 Mar;139(3):341-3. doi: 10.1176/ajp.139.3.341.
5
Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.氯氮平治疗精神分裂症患者的抗精神病药物所致迟发性运动障碍、帕金森症及慢性静坐不能。
J Clin Psychiatry. 1997 Jul;58(7):318-22. doi: 10.4088/jcp.v58n0706.
6
Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism.迟发性运动障碍和抗精神病药物所致帕金森症的精神分裂症患者脑脊液中的神经化学研究结果
Jpn J Psychiatry Neurol. 1986 Jun;40(2):189-94. doi: 10.1111/j.1440-1819.1986.tb03141.x.
7
Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?抗精神病药物戒断 6 个月是否足以区分药物引起的帕金森病与帕金森病?
Int J Neurosci. 2013 Mar;123(3):170-4. doi: 10.3109/00207454.2012.732976. Epub 2013 Jan 4.
8
Coexistent tardive dyskinesia and parkinsonism.迟发性运动障碍与帕金森病共存。
Clin Neuropharmacol. 1987 Dec;10(6):511-21. doi: 10.1097/00002826-198712000-00002.
9
Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.抗精神病药物所致帕金森综合征:临床特征及左旋多巴治疗结果
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):850-4. doi: 10.1136/jnnp.51.6.850.
10
Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia.迟发性运动障碍患者中抗精神病药物所致帕金森综合征的临床及器械评估
Biol Psychiatry. 1991 Jan 15;29(2):139-48. doi: 10.1016/0006-3223(91)90042-k.

引用本文的文献

1
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.药物性帕金森综合征(DIP)管理的最新观点:来自临床的见解
Ther Clin Risk Manag. 2022 Dec 20;18:1129-1142. doi: 10.2147/TCRM.S360268. eCollection 2022.
2
Use of antipsychotics and long-term risk of parkinsonism.抗精神病药物的使用与帕金森病长期风险的关联。
Neurol Sci. 2022 Apr;43(4):2545-2553. doi: 10.1007/s10072-021-05650-z. Epub 2021 Oct 15.
3
Tremor analysis separates Parkinson's disease and dopamine receptor blockers induced parkinsonism.
震颤分析可区分帕金森病和多巴胺受体阻滞剂所致帕金森综合征。
Neurol Sci. 2017 May;38(5):855-863. doi: 10.1007/s10072-017-2852-6. Epub 2017 Feb 22.
4
Parkinsonism and tremor disorders. A clinical approach.帕金森病与震颤障碍。一种临床方法。
Libyan J Med. 2007 Jun 1;2(2):66-72. doi: 10.4167/061222.
5
Treatment of psychosis in Parkinson's disease: safety considerations.帕金森病精神病的治疗:安全性考量
Drug Saf. 2003;26(9):643-59. doi: 10.2165/00002018-200326090-00004.
6
Drug-induced movement disorders.药物性运动障碍
Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004.
7
Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.抗精神病药物所致帕金森综合征:停用抗精神病药物后MRI表现与临床病程的关系
J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):213-6. doi: 10.1136/jnnp.60.2.213.
8
Drug-induced parkinsonism in the aged. Recognition and prevention.老年人药物性帕金森综合征。识别与预防。
Drugs Aging. 1994 Aug;5(2):127-32. doi: 10.2165/00002512-199405020-00006.